Mechanism of Paclitaxel Combined with Cisplatin Regulating NOD1, NF- κ B , and R1P2 Signal in the Treatment of Breast Cancer

doi:10.11748/bjmy.issn.1006-1703.2018.12.037

PDF(4193 KB)

Labeled Immunoassays and Clinical Medicine ›› 2018, Vol. 25 ›› Issue (12) : 1900-1903. DOI: 10.11748/bjmy.issn.1006-1703.2018.12.037

Mechanism of Paclitaxel Combined with Cisplatin Regulating NOD1, NF- κ B , and R1P2 Signal in the Treatment of Breast Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 25(12): 1900-1903 https://doi.org/10.11748/bjmy.issn.1006-1703.2018.12.037

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(4193 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2018-08-24	2018-10-26	2018-12-20
Issue Date
2019-02-22

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS